The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma
Clinical trial NCT02189109 · COMPLETED
Trial details
- NCT number
- NCT02189109
- Sponsor
- NuvOx LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2017-08-31
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.